Replies to post #21738 on Amarin Corp Plc (AMRN)

[labner]

link to adcom

can be found on our Vascepa initiative website. Session 4 is what you want to hear (1:09, Coleman is asked why different standards in regard to required outcome studies are applied)Unfortunately he will give you the same answer as he knows how to cover his tracks. In addition, the argument makes sense in that lowering ldl is a proven CVD reducers, whereas EPA, via lowering trigs has not been studied or proven (thus the need for the Reduce-it trial)

http://epadruginitiative.com/